Presentation Information
[LMO4-9]A Randomized Phase II Trial of Granisetron vs. Granisetron Plus ME2136 for PONV Prevention in Moderate- to High-Risk Patients Undergoing Pulmonary Resection:Trial in Progress
Kazuki Hayasaka1, Shinya Katsumata1, Keigo Matsushima1, Tatsuya Masuda1, Hideaki Kojima1, Hayato Konno1, Naoya Yokomakura1, Mitsuhiro Isaka1, Kenta Murotani2,3, Yasuhisa Ohde1 (1.Division of Thoracic Surgery, Shizuoka Cancer Center, Nagaizumi, Japan, 2.School of Medical Technology, Kurume University, Kurume, Japan, 3.Biostatistics Center, Kurume University, Kurume, Japan)
Password required to view
Comment
To browse or post comments, you must log in.Log in